Skip to main content
. 2020 Mar 9;10:89. doi: 10.1038/s41398-020-0768-z

Fig. 1. Study design.

Fig. 1

After a screening visit to assess their eligibility, participants attended three more visits. TSPO-PET signal was collected at 2 timepoints (before and after the immune challenge); data on peripheral inflammation and clinical symptoms were collected at 6 timepoints (2 before and 4 after the immune challenge).